Transdermal contraceptive formulations, methods and devices
US5122382A · kind A · utility
56Cited by
3References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 29, 1990 |
| Grant date | Jun 16, 1992 |
| Priority date | — |
| Expiry date | Oct 29, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compositions and methods for the transdermal administration of a contraceptively effective amount of a synthetic 19-nor-progesterone (ST-1435) and an estrogen, in combination, together with a suitable permeation enhancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.